{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:21:00Z","timestamp":1775258460498,"version":"3.50.1"},"reference-count":46,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Radiotherapy for head and neck cancer must balance tumour control with late toxicities such as dysphagia and xerostomia. Recent retrospective studies suggest that the margin from the gross tumour volume (GTV) to the high-dose clinical target volume (CTV1) may not be critical for local control, while larger irradiated volumes increase the risk of toxicity. The study quantifies potential reductions in dose to organs at risk (OARs) and predicted dysphagia risk when the standard 5 mm GTV-to-CTV1 margin is eliminated in oropharyngeal cancer.\nPatient\/material and methods: Retrospectively 30 oropharyngeal cancer patients treated consecutively during 2023 according to the DAHANCA guidelines (5 mm GTV-to-CTV1 margin) were selected. For each patient, a standard plan and a modified experimental plan (CTV1 = GTV, and CTV2 reduced by 5 mm accordingly) were generated using Pinnacle3 Auto-Planning. All plans met the DAHANCA target coverage and OAR dose constraints. Dose-volume data for relevant OARs were extracted and compared in MATLAB. Normal tissue complication probability (NTCP) model for dysphagia was applied.\nResults: Margin elimination reduced high-dose CTV volumes by 70%, yielding significant dose reductions to multiple OARs. Mean doses to the upper\/middle pharyngeal constrictors decreased by around 4\u20135 Gy (p &lt; 0.001) and to the contralateral submandibular gland by ~5 Gy (p &lt; 0.001). These dosimetric gains correspond to an estimated median \u0394NTCP of 6.0% of late grade \u2265\u20092 dysphagia. Target coverage and conformity were maintained in all plans.\nInterpretation: Omitting the high-risk CTV margin can substantially reduce the dose to dysphagia-\u00adassociated OAR without compromising target coverage. This approach shows promise for improving patient-reported swallowing outcomes and warrants clinical evaluation.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.44049","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:39:21Z","timestamp":1757576361000},"page":"1205-1211","source":"Crossref","is-referenced-by-count":1,"title":["Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-6069","authenticated-orcid":false,"given":"Christian R\u00f8nn","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-0786","authenticated-orcid":false,"given":"Anders S.","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Hazell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-5469","authenticated-orcid":false,"given":"Sarah W","family":"Stougaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3929","authenticated-orcid":false,"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8179","authenticated-orcid":false,"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-6033","authenticated-orcid":false,"given":"Jesper Grau","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0915-6880","authenticated-orcid":false,"given":"Ruta","family":"Zukauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"126276","doi-asserted-by":"crossref","unstructured":"Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MWS, et al. Late dysphagia after radiotherapy\u2010based treatment of head and neck cancer. Cancer. 2012;118:5793\u20139.","DOI":"10.1002\/cncr.27631"},{"key":"126277","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/cncr.27631","DOI":"10.1002\/cncr.27631"},{"key":"126278","doi-asserted-by":"crossref","unstructured":"Huynh T-TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, et al. Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters. Radiother Oncol. 2024;190:110044.","DOI":"10.1016\/j.radonc.2023.110044"},{"key":"126279","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110044","DOI":"10.1016\/j.radonc.2023.110044"},{"key":"126280","doi-asserted-by":"crossref","unstructured":"Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, et al. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, con-trolled trial. Lancet Oncol. 2023;24:868\u201380.","DOI":"10.1016\/S1470-2045(23)00265-6"},{"key":"126281","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(23)00265-6","DOI":"10.1016\/S1470-2045(23)00265-6"},{"key":"126282","doi-asserted-by":"crossref","unstructured":"Hansen CR, Johansen J, Samsoe E, Andersen E, Petersen JBB, Jensen K, et al. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy. Radiother Oncol. 2018;126:43\u20137.","DOI":"10.1016\/j.radonc.2017.09.019"},{"key":"126283","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2017.09.019","DOI":"10.1016\/j.radonc.2017.09.019"},{"key":"126284","unstructured":"Zukauskaite R, Hansen CR, Grau C, Samsoe E, Johansen J, Petersen JBB, et al. Local recurrences after curative IMRT for HNSCC: effect of"},{"key":"126285","doi-asserted-by":"crossref","unstructured":"different GTV to high-dose CTV margins. Radiother Oncol. 2018;126:48\u201355.","DOI":"10.1016\/j.radonc.2017.11.024"},{"key":"126286","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2017.11.024","DOI":"10.1016\/j.radonc.2017.11.024"},{"key":"126287","doi-asserted-by":"crossref","unstructured":"Zukauskaite R, Kristensen MH, Eriksen JG, Johansen J, Sams\u00f8e E, Johnsen L, et al. Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin. Radiother Oncol. 2024;196:110284.","DOI":"10.1016\/j.radonc.2024.110284"},{"key":"126288","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110284","DOI":"10.1016\/j.radonc.2024.110284"},{"key":"126289","doi-asserted-by":"crossref","unstructured":"Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Sams\u00f8e E, Maare C, et al. High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma \u2013 a DAHANCA 19 study. Clin Transl Radiat Oncol. 2024;46:100772.","DOI":"10.1016\/j.ctro.2024.100772"},{"key":"126290","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100772","DOI":"10.1016\/j.ctro.2024.100772"},{"key":"126291","unstructured":"Stougaard SW, Zukauskaite R, R\u00f6ttger R, Lorenzen EB, Konrad ML, Nielsen CP, et al. Impact of GTV-CTV margin and other predictors on radiation-induced dysphagia in head and neck cancer patients. Acta Oncol. 2025:64."},{"key":"126292","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2025.44021"},{"key":"126293","doi-asserted-by":"crossref","unstructured":"Zukauskaite R, Eriksen J, Johansen J, Sams\u00f8e E, Kristensen MH, Johnsen L, et al. Late dysphagia after changes in high-dose CTV margins for head and neck cancer patients. Acta Oncol. 2025:64.","DOI":"10.1016\/S0167-8140(24)02012-7"},{"key":"126294","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2025.43924"},{"key":"126295","doi-asserted-by":"crossref","unstructured":"Jensen K, Friborg J, Hansen CR, Samsoe E, Johansen J, Andersen M, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radio-therapy guidelines. Radiother Oncol. 2020;151:149\u201351.","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"126296","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2020.07.037","DOI":"10.1016\/j.radonc.2020.07.037"},{"key":"126297","doi-asserted-by":"crossref","unstructured":"Jensen K, Holm AIS, Eriksen JG, Skyt PS, Grau C, Bernsdorf M, et al. Danish Head and Neck Cancer Group (DAHANCA) Radiotherapy Quality Assurance Guidelines 2025. Update and new chapters: planning of complex targets, hypofractionation, planning of reirradiation, target definition after induction chemotherapy, and clarification of the guidelines for elective targets. Radiother Oncol. 2025;210:111028.","DOI":"10.1016\/j.radonc.2025.111028"},{"key":"126298","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111028","DOI":"10.1016\/j.radonc.2025.111028"},{"key":"126299","doi-asserted-by":"crossref","unstructured":"Hansen CR, Crijns W, Hussein M, Rossi L, Gallego P, Verbakel W, et al. Radiotherapy Treatment plannINg study Guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies. Radiother Oncol. 2020;153:67\u201378.","DOI":"10.1016\/j.radonc.2020.09.033"},{"key":"126300","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2020.09.033","DOI":"10.1016\/j.radonc.2020.09.033"},{"key":"126301","doi-asserted-by":"crossref","unstructured":"Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110:172\u201381.","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"126302","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2013.10.010","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"126303","doi-asserted-by":"crossref","unstructured":"Hansen CR, Christiansen RL, Nielsen TB, Bertelsen AS, Johansen J, Brink C. Comparison of three immobilisation systems for radiation therapy in head and neck cancer. Acta Oncol. 2014;53:423\u20137.","DOI":"10.3109\/0284186X.2013.813966"},{"key":"126304","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/0284186X.2013.813966","DOI":"10.3109\/0284186X.2013.813966"},{"key":"126305","doi-asserted-by":"crossref","unstructured":"Bertelsen A, Hansen CR, Johansen J, Brink C. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother Oncol. 2010;95:142\u20138.","DOI":"10.1016\/j.radonc.2010.01.011"},{"key":"126306","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2010.01.011","DOI":"10.1016\/j.radonc.2010.01.011"},{"key":"126307","doi-asserted-by":"crossref","unstructured":"Van Den Bosch L, Van Der Schaaf A, Van Der Laan HP, Hoebers FJP, Wijers OB, Van Den Hoek JGM, et al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment. Radiother Oncol. 2021;157:147\u201354.","DOI":"10.1016\/j.radonc.2021.01.024"},{"key":"126308","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.024","DOI":"10.1016\/j.radonc.2021.01.024"},{"key":"126309","doi-asserted-by":"crossref","unstructured":"Pollock AE, Arons D, Alexander GS, Alicia D, Birkman KM, Molitoris JK, et al. Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy. Head Neck. 2023;45:1088\u201396.","DOI":"10.1002\/hed.27308"},{"key":"126310","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/hed.27308","DOI":"10.1002\/hed.27308"},{"key":"126311","doi-asserted-by":"crossref","unstructured":"Hansen CR, Jensen K, Smulders B, Holm AIS, Samsoe E, Nielsen MS, et al. Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35. Radiother Oncol. 2023;190:109812.","DOI":"10.1016\/j.radonc.2023.109812"},{"key":"126312","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109812","DOI":"10.1016\/j.radonc.2023.109812"},{"key":"126313","doi-asserted-by":"crossref","unstructured":"Al-Mamgani A, Kessels R, Janssen T, Navran A, van Beek S, Carbaat C, et al. The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: significant acute and late toxicity reduction. Radiother Oncol. 2022;168:16\u201322.","DOI":"10.1016\/j.radonc.2022.01.013"},{"key":"126314","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2022.01.013","DOI":"10.1016\/j.radonc.2022.01.013"},{"key":"126315","doi-asserted-by":"crossref","unstructured":"Al-Mamgani A, Kessels R, Navran A, Hamming-Vrieze O, Zuur CL, Paul de Boer J, et al. Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes. Radiother Oncol. 2021;162:170\u20137.","DOI":"10.1016\/j.radonc.2021.07.016"},{"key":"126316","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2021.07.016","DOI":"10.1016\/j.radonc.2021.07.016"},{"key":"126317","doi-asserted-by":"crossref","unstructured":"Zukauskaite R, Rumley CN, Hansen CR, Jameson MG, Trada Y, Johansen J, et al. Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients. Clin Transl Radiat Oncol. 2022;36:121\u20136.","DOI":"10.1016\/j.ctro.2022.08.005"},{"key":"126318","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctro.2022.08.005","DOI":"10.1016\/j.ctro.2022.08.005"},{"key":"126319","unstructured":"Nielsen M, Hansen CR, Brink C, Bertelsen AS, Kristiansen C, Jeppesen SS, et al. Efficient and accurate stereotactic radiotherapy using flattening filter free beams and HexaPOD robotic tables. J Radiosurgery SBRT. 2016;4:153\u201361."},{"key":"126320","doi-asserted-by":"crossref","unstructured":"Hussein M, Heijmen BJM, Verellen D, Nisbet A. Automation in intensity modulated radiotherapy treatment planning \u2013 a review of recent innovations. Br J Radiol. 2018;91:20180270.","DOI":"10.1259\/bjr.20180270"},{"key":"126321","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1259\/bjr.20180270","DOI":"10.1259\/bjr.20180270"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44049\/51433","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44049\/51433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:39:35Z","timestamp":1757576375000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/44049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.44049","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}